title: Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases.
authors.affiliation: Division of Gastroenterology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: Ali
authors.initials: A
authors.lastname: Rezaie
references.citation: N Engl J Med. 2013 Aug 22;369(8):699-710
references.pmid: 23964932
references.citation: N Engl J Med. 2013 Aug 22;369(8):711-21
references.pmid: 23964933
references.citation: Gastroenterology. 2013 Nov;145(5):996-1006
references.pmid: 23896172
references.citation: Dig Dis. 2012;30 Suppl 3:140-4
references.pmid: 23295705
references.citation: Curr Drug Targets. 2013 Nov;14(12):1433-43
references.pmid: 23980911